INCYTE CORPORATION Amortization of Intangible Assets
INCYTE CORPORATION (INCY) reported Amortization of Intangible Assets of $26.70 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-02-10
- INCYTE CORPORATION amortization of intangible assets for fiscal 2025 was $26.70M, a 13.14% increase from fiscal 2024.
- INCYTE CORPORATION amortization of intangible assets for fiscal 2024 was $23.60M, a 4.89% increase from fiscal 2023.
- INCYTE CORPORATION amortization of intangible assets for fiscal 2023 was $22.50M, a 4.65% increase from fiscal 2022.
- INCYTE CORPORATION amortization of intangible assets for fiscal 2022 was $21.50M, a 0.00% change from fiscal 2021.
| Period end | Amortization of Intangible Assets 12 month |
|---|---|
| 2025-12-31 | $26.70M 10-K · filed 2026-02-10 |
| 2024-12-31 | $23.60M 10-K · filed 2026-02-10 |
| 2023-12-31 | $22.50M 10-K · filed 2026-02-10 |
| 2022-12-31 | $21.50M 10-K · filed 2025-02-10 |
| 2021-12-31 | $21.50M 10-K · filed 2024-02-13 |
| 2020-12-31 | $21.50M 10-K · filed 2023-02-07 |
| 2019-12-31 | $21.50M 10-K · filed 2022-02-08 |
| 2018-12-31 | $21.50M 10-K · filed 2021-02-09 |
| 2017-12-31 | $21.50M 10-K · filed 2020-02-13 |
| 2016-12-31 | $12.60M 10-K · filed 2019-02-14 |
| 2013-12-31 | $1.70M 10-K · filed 2014-02-21 |
| 2012-12-31 | $2.10M 10-K · filed 2014-02-21 |
| 2011-12-31 | $2.20M 10-K · filed 2014-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |